Top Markets
Coin of the day
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Classificação em ações #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Preço da ação
$8.46
Última sincronização: 2026-08-28
Valor de mercado
$514.33M
Variação (1 dia)
-2.08%
Variação (1 ano)
128.03%
País
US
Negociar Kyverna Therapeutics, Inc. (KYTX)

Categoria

Histórico de desdobramentos de ações de Kyverna Therapeutics, Inc. (KYTX)
As ações Kyverna Therapeutics, Inc. (símbolo: KYTX) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 31, 2026.
Uma ação KYTX comprada antes de Aug 31, 2026 equivaleria hoje a 0 ações KYTX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH